255 related articles for article (PubMed ID: 16898365)
1. Treatment of multidrug-resistant tuberculosis: evidence and controversies.
Caminero JA; ; ;
Int J Tuberc Lung Dis; 2006 Aug; 10(8):829-37. PubMed ID: 16898365
[TBL] [Abstract][Full Text] [Related]
2. Moving forward with evidence and controversies: the challenges of MDR-TB.
Chiang CY; Van Deun A; Caminero JA
Int J Tuberc Lung Dis; 2006 Aug; 10(8):827. PubMed ID: 16898363
[No Abstract] [Full Text] [Related]
3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
Ormerod LP
Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997.
Frieden TR; Munsiff SS; Ahuja SD
Int J Tuberc Lung Dis; 2007 Jan; 11(1):116. PubMed ID: 17217141
[No Abstract] [Full Text] [Related]
6. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].
Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M
Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681
[TBL] [Abstract][Full Text] [Related]
7. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
8. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
[TBL] [Abstract][Full Text] [Related]
9. Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh.
Van Deun A; Salim MA; Das AP; Bastian I; Portaels F
Int J Tuberc Lung Dis; 2004 May; 8(5):560-7. PubMed ID: 15137531
[TBL] [Abstract][Full Text] [Related]
10. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
[TBL] [Abstract][Full Text] [Related]
11. National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
Ti T; Lwin T; Mar TT; Maung W; Noe P; Htun A; Kluge HH; Wright A; Aziz MA; Paramasivan CN
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1111-6. PubMed ID: 17044203
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment to increase the success rate of multidrug-resistant tuberculosis.
Man MA; Nicolau D
Eur J Cardiothorac Surg; 2012 Jul; 42(1):e9-12. PubMed ID: 22531273
[TBL] [Abstract][Full Text] [Related]
13. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
16. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
17. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
[TBL] [Abstract][Full Text] [Related]
18. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
19. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
Hamid Salim A; Aung KJ; Hossain MA; Van Deun A
Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
[TBL] [Abstract][Full Text] [Related]
20. Thai drug-resistant tuberculosis predictive scores.
Boonsarngsuk V; Tansirichaiya K; Kiatboonsri S
Singapore Med J; 2009 Apr; 50(4):378-84. PubMed ID: 19421681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
